Salud financiera de hoja de balance de Unichem Laboratories
Salud financiera controles de criterios 5/6
Unichem Laboratories tiene un patrimonio de accionistas total de ₹24.0B y una deuda total de ₹2.7B, lo que sitúa su ratio deuda-patrimonio en 11.2%. Sus activos y pasivos totales son ₹33.1B y ₹9.1B respectivamente. El BAIT de Unichem Laboratories es de ₹526.1M, por lo que su ratio de cobertura de intereses es de 3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹2.0B.
Información clave
11.2%
Ratio deuda-patrimonio
₹2.68b
Deuda
| Ratio de cobertura de intereses | 3x |
| Efectivo | ₹1.98b |
| Patrimonio | ₹24.01b |
| Total pasivo | ₹9.10b |
| Activos totales | ₹33.11b |
Actualizaciones recientes sobre salud financiera
Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01
Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26
Recent updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹18.3B) de UNICHEMLAB superan a sus pasivos a corto plazo (₹8.2B).
Pasivo a largo plazo: Los activos a corto plazo de UNICHEMLAB (₹18.3B) superan a sus pasivos a largo plazo (₹907.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (2.9%) de UNICHEMLAB se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de UNICHEMLAB ha crecido de 7.3% a 11.2% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Aunque no es rentable UNICHEMLAB tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.
Pronóstico de cash runway: UNICHEMLAB no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 33.6% al año.